Registry Platform Ovarian and Endometrial Cancer
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 1375
- Registration Number
- NCT05129969
- Locations
- 🇩🇪
Multiple sites all over Germany, Multiple Locations, Germany
Registry Platform Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 500
- Registration Number
- NCT04867525
- Locations
- 🇩🇪
Multiple sites all over germany, Multiple Locations, Germany
Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion
- Conditions
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 88
- Registration Number
- NCT04557813
- Locations
- 🇩🇪
Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany
🇩🇪Centrum für Hämatologie und Onkologie Bethanien, Frankfurt, Germany
🇩🇪Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg, Germany
Liver Cancer Registry Platform
- Conditions
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 1000
- Registration Number
- NCT04510740
- Locations
- 🇩🇪
Multiple sites all over germany, Multiple Locations, Germany
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
- Conditions
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 499
- Registration Number
- NCT04389541
- Locations
- 🇩🇪
Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg, Germany
🇩🇪Hämatologisch-Onkologische Praxis Altona (HOPA), Hamburg, Germany
🇩🇪Klinikum Darmstadt, Onkologisches Studienzentrum, Darmstadt, Germany
Registry Platform Gastric/Esophageal Cancer (SAPHIR)
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 900
- Registration Number
- NCT04290806
- Locations
- 🇩🇪
Multiple sites, Gemany, Multiple Locations, Germany
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 154
- Registration Number
- NCT03911219
- Locations
- 🇩🇪
Gemeinschaftspraxis Dr. Heinrich, Prof. Dr. Bangerter, Augsburg, Germany
🇩🇪Hämato- Onkologische Praxis im Medicum, Bremen, Germany
🇩🇪MVZ des Städtischen Klinikums Dessau GmbH, Dessau, Germany
A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- iOMEDICO AG
- Registration Number
- NCT03811418
- Locations
- 🇩🇪
iOMEDICO AG, Freiburg, Baden-Wuerttemberg, Germany
Patient Preference for Pegfilgrastim (Neulasta®) Application Forms
- Conditions
- Interventions
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 404
- Registration Number
- NCT03619993
- Locations
- 🇩🇪
Research Site, Würselen, Germany
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2023-01-19
- Lead Sponsor
- iOMEDICO AG
- Target Recruit Count
- 41
- Registration Number
- NCT03462251
- Locations
- 🇩🇪
Klinikum Mittelbaden Baden-Baden Balg, Baden-Baden, Germany
🇩🇪Uniklinik RWTH Aachen, Gynäkologie und Geburtsmedizin, Aachen, Germany
🇩🇪Gemeinschaftspraxis für Hämatologie und Onkologie, Westerstede, Germany